Latest Breaking News On - Nutra pharma corp - Page 1 : vimarsana.com

Head-To-Head Survey: Nutra Pharma (OTCMKTS:NPHC) versus FitLife Brands (NASDAQ:FTLF)

Financial Survey: FitLife Brands (NASDAQ:FTLF) vs. Nutra Pharma (OTCMKTS:NPHC)

Head-To-Head Comparison: Akanda (NASDAQ:AKAN) vs. Nutra Pharma (OTCMKTS:NPHC)

Akanda (NASDAQ:AKAN – Get Rating) and Nutra Pharma (OTCMKTS:NPHC – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, dividends, profitability, valuation, institutional ownership, analyst recommendations and earnings. Analyst Recommendations This is a breakdown of current ratings for […]

Head to Head Review: Ayr Wellness (OTCMKTS:AYRWF) versus Nutra Pharma (OTCMKTS:NPHC)

Nutra Pharma (OTCMKTS:NPHC – Get Rating) and Ayr Wellness (OTCMKTS:AYRWF – Get Rating) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk. Profitability This table compares Nutra Pharma and Ayr Wellness’ […]

Nutra Pharma Announces First Manufacturing Agreement

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Nutra Pharma Expands Manufacturing Capabilities

Nutra Pharma is providing updates on their work in improving manufacturing scale and capabilities for new product launches for their OTC drugs and.

SEC Proposes Sweeping New Regulatory and Enforcement Regime for Private Funds and Private Market Participants | Quinn Emanuel Urquhart & Sullivan, LLP

Over a two week period at the end of January and beginning of February, the U.S. Securities and Exchange Commission (“SEC” or “Commission”) proposed new rules and rule amendments that.

Nutra Pharma Files Updated Provisional Patent for Nerve Agent Counter Measures

Nutra Pharma Corporation: Nutra Pharma Announces Private Label Expansion of their Over-The-Counter Pain Relievers

Nutra Pharma is announcing the first private label agreement in expansion of their line of over-the-counter pain relievers and anti-inflammatory drugs Plantation, Florida (Newsfile Corp. - June 4, 2021)

Nutra Pharma Announces Influencer and Social Media Campaign for | The Kingston Whig Standard

Article content Plantation, Florida–(Newsfile Corp. – May 24, 2021) – Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today their plans for expanding the marketing of their over-the-counter pain relievers and anti-inflammatory products by working with influencers on several social media platforms. These will include celebrities as well as professional and Olympic athletes that have benefitted from Nutra Pharma’s products. We apologize, but this video has failed to load. Try refreshing your browser.